Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib as Maintenance Therapy in Advanced NSCLC
NCT00693992Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2008
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sunitinib in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Jun 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00693992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693992.